🔎 Trials Near Me

Home › Type 2 Diabetes › Texas

Pag-aaral pangklinika para sa Type 2 Diabetes sa Texas

58 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • Baylor Scott & White, Temple
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • Houston Methodist, Houston
  • Baylor Scott & White, Temple
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06906640

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Texas Diabetes and Endocrinology - Central Austin, Austin
  • South Texas Research Institute - Brownsville, Brownsville
  • Privia Medical Group Gulf Coast, PLLC, Conroe
  • at 10 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Clinical Research - Austin, Austin
  • South Texas Research Institute - Brownsville, Brownsville
  • Headlands Research - Brownsville, Brownsville
  • at 25 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Horizon Clinical Research Group, Cypress
  • Cardiovascular Specialists of Willowbrook, Houston
  • Texas Cardiology Associates of Houston, Kingwood
  • at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Amarillo Med Spec LLP, Amarillo
  • Texas Diabetes & Endocrinology, Austin
  • North Texas Endocrine Center, Dallas
  • at 6 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07817251

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06593327

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Hendrick Health, Abilene
  • Gadolin Research, Beaumont
  • CardioVoyage, LLC, Greenville
  • at 10 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06112418

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

  • Endeavor Clinical Trials, San Antonio
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
  • VIP Trials, San Antonio
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

  • The University of Texas Health Science Center at San Antonio, San Antonio
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02969798

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • IMA Clinical Research Austin, Austin
  • Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
  • Velocity Clinical Research, Dallas, Dallas
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, DeSoto
  • Research Site, El Paso
  • Research Site, Houston
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Austin
  • AURORA-2 Clinical Site, Brownsville
  • AURORA-2 Clinical Site, DeSoto
  • at 10 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
  • SMS Clinical Research, LLC - 400 W. Kearney St, Mesquite
  • at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Headlands Research Brownsville, Brownsville
  • Velocity Clinical Research, Dallas
  • South Texas Research Institute - Edinburg, Edinburg
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Juno Research, Houston
  • Southern Endocrinology Associates, Mesquite
  • Texas Diabetes & Endocrinology, P.A., Round Rock
  • at 2 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • IMA Clinical Research, Austin
  • Private Practice - Dr. Laila A. Hassan, Houston
  • Radiance Clinical Research, Lampasas
  • at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07668388

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  • University of Texas Southwestern Medical Center, Dallas
  • JCCT- Juno NW Houston, Houston
  • Consano Clinical Research, LLC, Shavano Park
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Arlington Nephrology, PLLC., Arlington
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
  • at 10 pa
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Dallas
  • Research Site, Houston
  • Research Site, Houston
  • at 6 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Amir Ali Hassan, MD, PA, Houston
  • Consano Clinical Research, LLC, Shavano Park
Nagre-recruitPhase 3
Edad 10 hanggang 18 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Austin, Austin
  • Velocity Clinical Research - Dallas, Dallas
  • Juno Research, LLC, Houston
  • at 8 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
  • Biopharma Informatic, LLC, Houston
  • at 5 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Elligo Clinical Research Center, Austin
  • Johnson County Clinical Trials Juno Bellaire, Bellaire
  • Osvaldo A Brusco MD PA, Corpus Christi
  • at 2 pa
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • PharmaTex Research, Amarillo
  • Pinnacle Clinical Research, Austin
  • Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
  • at 20 pa
Nagre-recruitPhase 3
Edad 45 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Dallas
  • Research Site, McKinney
  • Research Site, Paris
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07662109

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  • Texas Diabetes & Endocrinology, Austin
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599982

Quantifying Hepatic Mitochondrial Fluxes in Humans

  • Texas Diabetes Institute - University Health System, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05305287

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

  • Research Site, San Antonio
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07024823

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Research Institute of Dallas, Dallas
  • Texas Childrens Hospital, Houston
  • UT Health Houston, Houston
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

  • UT Southwestern Medical Center, Dallas
Nagre-recruitPhase 1/2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06143566

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

  • Research Site, Houston
  • Research Site, Round Rock
  • Research Site, San Antonio
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07664553

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • Texas Diabetes and Endocrinology, Austin
  • Tekton Research, McKinney
  • Tekton Research, San Antonio
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07521475

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Baylor College of Medicine, Houston
Nagre-recruit
Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07579702

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

  • Brooke Army Medical Center, San Antonio
Nagre-recruit
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07674628

SGLTi, Hepatic Glucose Production and Ketogenesis

  • Texas Diabetes Institute/UH, San Antonio
Nagre-recruitPhase 1
Edad 30 hanggang 75 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT05960656

Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.